Background-Despite the recent discovery of four genes responsible for
up to 90% of all cases of hereditary non-polyposis colorectal cancer (
HNPCC), there will still be families in whom predictive testing is not
possible. A phenotypic biomarker would therefore be useful. An upward
s shift of the proliferative compartment in colonic crypts is reported
to be one of the earliest changes in premalignant mucosa. Aims-To ass
ess the role of crypt cell, proliferation as a phenotypic biomarker in
HNPCC. Patients-Thirty five patients at 50% risk of carrying the HNPC
C gene (21 of whom subsequently underwent predictive testing and hence
gene carrier status was known) and 18 controls. Methods-Crypt cell pr
oliferation was measured at five sites in the colon using two differen
t techniques. Labelling index was determined using the monoclonal anti
body MIB1 and whole crypt mitotic index was measured using the microdi
ssection and crypt squash technique. The distribution of proliferating
cells within the crypts was also assessed. Results-There were no sign
ificant differences in the total labelling index or mean number of mit
oses per crypt, nor in the distribution of proliferating cells within
the crypt, between the study and control groups at any site. When the
21 patients in whom gene carrier status was known were analysed separa
tely there were no significant differences in the measured indices of
proliferation between the HNPCC gene carriers and non-gene carriers. C
onclusion-Crypt cell proliferation is not a discriminative marker of g
ene carriage in HNPCC.